CorMedix
(NASDAQ) CRMD
CorMedix Financials at a Glance
Market Cap
$686.45M
Revenue (TTM)
$400.05M
Net Income (TTM)
$181.01M
EPS (TTM)
$2.10
P/E Ratio
4.17
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$8.76
Volume
813
Open
$8.55
Price
$8.76
Volume
813
Open
$8.55
Previous Close
$8.75
Daily Range
$8.42 - $8.84
52-Week Range
$6.13 - $14.96
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$8.76
Volume
813
Open
$8.55
Previous Close
$8.75
Daily Range
$8.42 - $8.84
52-Week Range
$6.13 - $14.96
Estimated Earnings Date
Aug 6, 2026
CRMD News
CRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CorMedix
Industry
Pharmaceuticals
Sector
Health CareEmployees
191
CEO
Joseph Todisco, MBA
Website
www.cormedix.comHeadquarters
Berkeley Heights, NJ 07922, US
CRMD Financials
Key Financial Metrics (TTM)
Gross Margin
85.83%
Operating Margin
48.41%
Net Income Margin
45.25%
Return on Equity
50.38%
Return on Capital
27.09%
Return on Assets
22.19%
Earnings Yield
23.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$686.45M
Shares Outstanding
78.45M
Volume
813
Avg. Volume
1.31M
Financials (TTM)
Gross Profit
$343.39M
Operating Income
$193.67M
EBITDA
$212.72M
Operating Cash Flow
$197.69M
Capital Expenditure
-$1.30M
Free Cash Flow
$196.39M
Cash & ST Invst.
$178.09M
Total Debt
$144.89M
CorMedix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$127.43M
+226.1%
Gross Profit
$105.12M
+180.4%
Gross Margin
82.50%
N/A
Market Cap
$686.45M
N/A
Market Cap/Employee
$10.73M
N/A
Employees
64
N/A
Net Income
$38.60M
+87.0%
EBITDA
$66.19M
+218.0%
Quarterly Fundamentals
Total Cash
$178.09M
+129.8%
Total Debt
$144.89M
+30300.5%
Accounts Receivable
$154.81M
+183.5%
Inventory
$30.73M
+310.4%
Long Term Debt
$144.89M
+47545.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
22.19%
N/A
Return on Invested Capital
28.20%
N/A
Free Cash Flow
$41.65M
+111.2%
Operating Cash Flow
$42.38M
+114.7%